Q32 Bio Inc.·4

Sep 30, 6:01 AM ET

Manke Isaac 4

4 · Q32 Bio Inc. · Filed Sep 30, 2024

Insider Transaction Report

Form 4
Period: 2024-04-01
Manke Isaac
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-01$13.42/sh+2,627$35,2542,627 total
    Exercise: $18.00Exp: 2034-03-31Common Stock (2,627 underlying)
Footnotes (2)
  • [F1]This option was granted in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive equity in lieu of cash compensation for services as a non-employee director of the Issuer.
  • [F2]The shares underlying this option vest in three equal quarterly installments on each of June 30, 2024, September 30, 2024 and December 31, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4